Newsfeeds - Spark Newswire

1 minute read

Legal
News

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted For VPO-227, A Novel Candidate For The Treatment Of Cholera

Today, 8:34 AM

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VPO-227 for the treatment of cholera.

VNDA

1 minute read

Vanda Pharmaceuticals Announced Notice of Opportunity for an FDA Hearing on Supplemental New Drug Application for HETLIOZ to Treat Jet Lag Disorder

By Charles Gross

Today, 8:34 AM

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the notice of opportunity for an FDA hearing on Vanda's Supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon) to treat jet lag disorder.

VNDA

1 minute read

Vanda Pharmaceuticals Q2 EPS $0.05 Misses $0.11 Estimate, Sales $64.40M Miss $67.00M Estimate

By Benzinga Newsdesk

Today, 8:34 AM

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 54.55 percent. This is a 70.59 percent decrease over earnings of $0.17 per share

VNDA

57 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:34 AM

On Friday, 1043 companies hit new 52-week lows.

AAOI

1 minute read

Vanda Pharmaceuticals Q1 EPS $(0.11) Misses $(0.01) Estimate, Sales $60.20M Beat $58.00M Estimate

By Benzinga Newsdesk

Today, 8:34 AM

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.01) by 1000 percent. This is a 173.33 percent decrease over earnings of $0.15 per

VNDA

30 minute read

Earnings Scheduled For May 5, 2022

By Benzinga Insights

Today, 8:34 AM

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

AAOI

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:34 AM

Wednesday's session saw 784 companies set new 52-week lows.

AADI

6 minute read

93 Biggest Movers From Friday

By Lisa Levin

Today, 8:34 AM

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.

AAOI

1 minute read

Jefferies Downgrades Vanda Pharmaceuticals to Hold, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 8:34 AM

Jefferies analyst Chris Howerton downgrades Vanda Pharmaceuticals (NASDAQ:VNDA) from Buy to Hold and lowers the price target from $24 to $12.

VNDA

1 minute read

Earnings

Vanda Pharmaceuticals: Q4 Earnings Insights

By Benzinga Insights

Today, 8:34 AM

Vanda Pharmaceuticals (NASDAQ:VNDA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

VNDA